Low-dose vaginal E2 tablets effectively treat atrophic vaginitis

Article

Twelve weeks of vaginal tablets with either 25 µg or 10 µg estradiol (E2) relieves vaginal symptoms, improves urogenital atrophy, decreases vaginal pH, and increases maturation of the vaginal and urethral epithelium in women with atrophic vaginitis, according to the findings of a multicenter, randomized, double-blind, placebo-controlled trial.

Twelve weeks of vaginal tablets with either 25 µg or 10 µg estradiol (E2) relieves vaginal symptoms, improves urogenital atrophy, decreases vaginal pH, and increases maturation of the vaginal and urethral epithelium in women with atrophic vaginitis, according to the findings of a multicenter, randomized, double-blind, placebo-controlled trial.

The study included 230 postmenopausal women. While improvements were greater with 25 µg than with 10 µg, both doses were effective; efficacy, at least with the 25 µg dose, was maintained to week 52.

Bachmann G, Lobo RA, Gut R, et al. Efficacy of low-dose estradiol vaginal tablets in the treatment of atrophic vaginitis: a randomized controlled trial. Obstet Gynecol. 2008;111:67-76.

Newsletter

Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.

Recent Videos
Neal Barnard, MD, FACC, highlights AMA's new breast cancer prevention guidelines | Image Credit: pcrm.org.
Zachary Wagner, PhD, discusses the harms of bias in reproductive care | Image Credit: ornsife.usc.edu.
Ciera Kirkpatrick, PhD, shows how TikTok is transforming cervical cancer awareness | Image Credit: linkedin.com.
Maria Gallo, PhD, discusses high attendance at crisis pregnancy centers | Image Credit: © x.com.
Related Content
© 2025 MJH Life Sciences

All rights reserved.